首页> 美国卫生研究院文献>Oncology Letters >Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer
【2h】

Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer

机译:双源CT灌注成像和MRI在原发性肝癌诊断中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of the present study was to evaluate the application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer. Sixty-three patients with primary liver cancer were selected between February 2015 and May 2016. All patients underwent examinations by dual-source CT perfusion imaging and MRI. The perfusion parameters of the focus center and normal liver parenchyma by CT examination and the hemodynamic parameters of the focus center and normal liver parenchyma by MRI examination were analyzed. The accuracy rates of the three detection methods (CT perfusion imaging, MRI, and combined examination) were analyzed and compared by ROC curves. Dual-source CT perfusion imaging revealed that blood flow and blood volume of the focus center were significantly higher than those of normal liver parenchyma (P<0.05). MRI examination showed that hepatic arterial perfusion and hepatic perfusion index of the focus center were significantly higher than those of normal liver parenchyma; portal venous perfusion of the focus center was significantly lower than that of normal liver parenchyma (P<0.05); the difference in total liver perfusion between the focus center and normal liver parenchyma was not significant (P>0.05); the accuracy rates of CT perfusion imaging, MRI, and combined examination were 76.19, 85.71, and 95.24% respectively; the area under the curve of CT perfusion imaging was 0.753 (P<0.05), the sensitivity was 79.2% and the specificity was 74.7%; the area under the curve of MRI was 0.846 (P<0.05), the sensitivity was 84.6%, and the specificity was 80.5%; the area under the curve of CT combined with MRI was 0.947 (P<0.05), the sensitivity was 94.6%, and the specificity was 86.5%. In conclusion, the effect of dual-source CT perfusion imaging combined with MRI for examination of primary liver cancer is superior to that of single use of CT or MRI, and has high clinical application and popularization value.
机译:本研究的目的是评估双源CT灌注成像和MRI在原发性肝癌诊断中的应用。在2015年2月至2016年5月之间,共选择了63例原发性肝癌患者。所有患者均接受了双源CT灌注成像和MRI检查。通过CT检查分析了焦点中心和正常肝实质的灌注参数,以及通过MRI检查了焦点中心和正常肝实质的血液动力学参数。分析了三种检测方法(CT灌注成像,MRI和联合检查)的准确率,并通过ROC曲线进行了比较。双源CT灌注成像显示,焦点中心的血流量和血容量明显高于正常肝实质(P <0.05)。 MRI检查显示,中心肝的肝动脉灌注和肝灌注指数明显高于正常肝实质。焦点中心的门静脉灌注明显低于正常肝实质(P <0.05);病灶中心与正常肝实质的总肝灌注差异无统计学意义(P> 0.05); CT灌注成像,MRI和联合检查的准确率分别为76.19、85.71和95.24%。 CT灌注成像曲线下面积为0.753(P <0.05),敏感性为79.2%,特异性为74.7%。 MRI曲线下面积为0.846(P <0.05),敏感性为84.6%,特异性为80.5%。 CT结合MRI的曲线下面积为0.947(P <0.05),敏感性为94.6%,特异性为86.5%。综上所述,双源CT灌注成像结合MRI检查对原发性肝癌的治疗效果优于一次性使用CT或MRI检查,具有较高的临床应用价值和推广价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号